A Phase 1/2 Study of CG001419 Tablets in Adult Subjects With Locally Advanced or Metastatic Solid Tumours Harbouring NTRK Gene Abnormalities

Clinical trial NCT07394374 · RECRUITING

Trial details

NCT number: NCT07394374
Sponsor: Cullgen (Shanghai),Inc
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumors Harboring NTRK Fusion NTRK NTRK Gene Fusion NTRK Fusion Positive

Start date: 2023-06-20
Primary completion: 2030-08-30
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.